Published in

Oxford University Press, Journal of Animal Science, 5(92), p. 1840-1849, 2014

DOI: 10.2527/jas.2013-7106

Links

Tools

Export citation

Search in Google Scholar

CELL BIOLOGY SYMPOSIUM: Impacts of maternal obesity on placental and gut inflammation and health1,2

Journal article published in 2014 by M. J. Zhu, M. Du ORCID, S. P. Ford
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Obesity in pregnant women is a growing public health concern that negatively affects fetal development and has long-term impacts on offspring health. The placenta plays an essential role in nutrient transport to the fetus and supports fetal growth and development. Maternal obesity induces an exacerbated pro-inflammatory milieu in the placenta providing an inflammatory environment for fetuses. The gut is one of the largest immune organs and mainly develops during the fetal stage. Maternal obesity (MO) and the corresponding inflammatory uteroplacental environment affect gut development, incurring inflammatory responses in the fetal intestine that further primes or programs the offspring gut to enhance inflammation and impair intestinal barrier integrity. This review summarizes the impact of MO on inflammatory responses in placenta and fetal intestine, and the long-term effects on offspring intestinal health. Because 'leaky gut' is one of the main etiological factors for a number of common diseases, including inflammatory bowel diseases, type I diabetes and related autoimmune diseases, the adverse effect of MO on the overall health of progeny is further discussed.